Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC, 10464-10466 [2020-03616]

Download as PDF 10464 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Marsh Blanton, M.D., 43 FR 27,616, 27,617 (1978). This rule derives from the text of two provisions of the CSA. First, Congress defined the term ‘‘practitioner’’ to mean ‘‘a physician . . . or other person licensed, registered, or otherwise permitted, by . . . the jurisdiction in which he practices . . . , to distribute, dispense, . . . [or] administer . . . a controlled substance in the course of professional practice.’’ 21 U.S.C. 802(21). Second, in setting the requirements for obtaining a practitioner’s registration, Congress directed that ‘‘[t]he Attorney General shall register practitioners . . . if the applicant is authorized to dispense . . . controlled substances under the laws of the State in which he practices.’’ 21 U.S.C. 823(f). Because Congress has clearly mandated that a practitioner possess state authority in order to be deemed a practitioner under the CSA, the DEA has held repeatedly that revocation of a practitioner’s registration is the appropriate sanction whenever he is no longer authorized to dispense controlled substances under the laws of the state in which he practices. See, e.g., James L. Hooper, 76 FR at 71,371–72; Sheran Arden Yeates, M.D., 71 FR 39,130, 39,131 (2006); Dominick A. Ricci, M.D., 58 FR 51,104, 51,105 (1993); Bobby Watts, M.D., 53 FR 11,919, 11,920 (1988); Frederick Marsh Blanton, 43 FR at 27,617. According to California statute, ‘‘[n]o person other than a physician . . . shall write or issue a prescription.’’ Cal. Health & Safety Code § 11150 (Westlaw 2019). Further, ‘‘physician,’’ as defined by California statute, is a person who is ‘‘licensed to practice’’ in California. Id. § 11024. Here, the undisputed evidence in the record is that Registrant currently lacks authority to practice medicine in California. As already discussed, a physician must be a licensed practitioner to dispense a controlled substance in California. Thus, because Registrant lacks authority to practice medicine in California and, therefore, is not authorized to handle controlled substances in California, Registrant is not eligible to maintain a DEA registration. Accordingly, I will order that Registrant’s DEA registration be revoked. Order Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. BD9798818 issued to Jaime C. David, M.D. This Order is effective March 25, 2020. Dated: January 31, 2020. Uttam Dhillon, Acting Administrator. DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–584] Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 24, 2020. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on December 9, 2019, Synthcon, LLC, 770 Wooten Road, Suite 101, Colorado Springs, Colorado 80915– 3538 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: [FR Doc. 2020–03626 Filed 2–21–20; 8:45 am] BILLING CODE 4410–09–P lotter on DSKBCFDHB2PROD with NOTICES Controlled substance Drug code Amphetamine ................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... 3-Fluoro-N-methylcathinone (3-FMC) .............................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. 4-Fluoro-N-methylcathinone (4-FMC) .............................................................................................................................. Pentedrone (a-methylaminovalerophenone) ................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................ Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... N,N-Dimethylamphetamine .............................................................................................................................................. Aminorex .......................................................................................................................................................................... 4-Methylaminorex (cis isomer) ........................................................................................................................................ Gamma Hydroxybutyric Acid ........................................................................................................................................... Methaqualone .................................................................................................................................................................. Mecloqualone .................................................................................................................................................................. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................. JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................ JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ........................................................................................... JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... Alpha-ethyltryptamine ...................................................................................................................................................... Ibogaine ........................................................................................................................................................................... CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................. CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ........................................... Lysergic acid diethylamide .............................................................................................................................................. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Mescaline ......................................................................................................................................................................... 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ............................................................................................ VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 1100 1105 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1585 1590 2010 2565 2572 6250 7035 7118 7173 7200 7203 7249 7260 7297 7298 7315 7348 7370 7381 7385 Schedule II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 10465 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices lotter on DSKBCFDHB2PROD with NOTICES Controlled substance Drug code 3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 2,5-Dimethoxyamphetamine ............................................................................................................................................ JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 3,4-Methylenedioxyamphetamine .................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. 5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. Alpha-methyltryptamine ................................................................................................................................................... Bufotenine ........................................................................................................................................................................ Diethyltryptamine ............................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... Psilocybin ......................................................................................................................................................................... Psilocyn ........................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 1-Phenylcyclohexylamine ................................................................................................................................................ 1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... Phencyclidine ................................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ N-Methyl-3-piperidyl benzilate ......................................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) .................................................................................................. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) .................................................................................................... 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ................................................................................................................. 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ........................................................................................................ 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ................................................................................................... 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) ..................................................................................................... 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) .............................................................................................. 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) .................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) ..................................................... 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) ..................................................... 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) .......................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Phenylacetone ................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ Alphaprodine .................................................................................................................................................................... Anileridine ........................................................................................................................................................................ Cocaine ............................................................................................................................................................................ Etorphine (except HCl) .................................................................................................................................................... Diphenoxylate .................................................................................................................................................................. Ecgonine .......................................................................................................................................................................... Heroin .............................................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Meperidine intermediate-A .............................................................................................................................................. Meperidine intermediate-B .............................................................................................................................................. Meperidine intermediate-C .............................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Morphine .......................................................................................................................................................................... Normorphine .................................................................................................................................................................... Acetorphine ...................................................................................................................................................................... U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ............................................................... AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. Acetylmethadol ................................................................................................................................................................ Allylprodine ...................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... Alphameprodine ............................................................................................................................................................... VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7455 7458 7460 7470 7471 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 8333 8501 8603 9010 9020 9041 9056 9170 9180 9200 9220 9230 9232 9233 9234 9273 9300 9313 9319 9547 9551 9601 9602 9603 9604 Schedule I I I I I I I I I I I I I I I I I I I I I I I II I II I I I I I I I I I I I I I I I I I I I I I I I II II II II II II I II II I II II II II II II II I I I I I I I I 10466 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Controlled substance Drug code Alphamethadol ................................................................................................................................................................. Benzethidine .................................................................................................................................................................... Betacetylmethadol ........................................................................................................................................................... Clonitazene ...................................................................................................................................................................... Diampromide ................................................................................................................................................................... Diethylthiambutene .......................................................................................................................................................... Dimethylthiambutene ....................................................................................................................................................... Ketobemidone .................................................................................................................................................................. Levo-alphacetylmethadol ................................................................................................................................................. 1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tilidine ............................................................................................................................................................................. Tapentadol ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... Para-Fluorofentanyl ......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... Beta-hydroxyfentanyl ....................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ Alpha-methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. Thiofentanyl ..................................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .......................................................................... Cyclopropyl Fentanyl ....................................................................................................................................................... Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ................................................................................... Morrissette Drive, Springfield, Virginia 22152. The company plans to manufacture the above-listed controlled substances as analytical reference standards for distribution to its customers. No other activities for these drug codes are authorized for this registration. In accordance with 21 CFR 1301.33(a), this is notice that on December 18, 2019, Stepan Company, 100 West Hunter Avenue, Maywood, New Jersey 07607– 1021 applied to be registered as a bulk manufacturer of the following basic class of controlled substances: SUPPLEMENTARY INFORMATION: Dated: February 3, 2020. William T. McDermott, Assistant Administrator. [FR Doc. 2020–03616 Filed 2–21–20; 8:45 am] BILLING CODE 4410–09–P Drug code Controlled substance DEPARTMENT OF JUSTICE Cocaine ........................ Ecgonine ....................... Drug Enforcement Administration [Docket No. DEA–580] lotter on DSKBCFDHB2PROD with NOTICES Dated: February 3, 2020. William T. McDermott, Assistant Administrator. Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 24, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 DATES: VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 I II II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. Bulk Manufacturer of Controlled Substances Application: Stepan Company ACTION: I 9041 9180 Schedule [FR Doc. 2020–03618 Filed 2–21–20; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 9605 9606 9607 9612 9615 9616 9619 9628 9648 9661 9663 9737 9739 9740 9743 9750 9780 9801 9812 9813 9814 9815 9821 9830 9831 9832 9833 9834 9835 9843 9845 9850 Schedule I I I I I I I I II I I II II II II I II II I I I I I I I I I I I I I I DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–586] Importer of Controlled Substances Application: Research Triangle Institute ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 25, 2020. Such persons may also file a written request for a hearing on the application on or before March 25, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, DATES: E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10464-10466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03616]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-584]


Bulk Manufacturer of Controlled Substances Application: Synthcon, 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before April 24, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:  In accordance with 21 CFR 1301.33(a), this 
is notice that on December 9, 2019, Synthcon, LLC, 770 Wooten Road, 
Suite 101, Colorado Springs, Colorado 80915-3538 applied to be 
registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Amphetamine........................            1100  II
Methamphetamine....................            1105  II
3-Fluoro-N-methylcathinone (3-FMC).            1233  I
Cathinone..........................            1235  I
Methcathinone......................            1237  I
4-Fluoro-N-methylcathinone (4-FMC).            1238  I
Pentedrone ([alpha]-                           1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC)..            1249  I
Naphyrone..........................            1258  I
N-Ethylamphetamine.................            1475  I
N,N-Dimethylamphetamine............            1480  I
Aminorex...........................            1585  I
4-Methylaminorex (cis isomer)......            1590  I
Gamma Hydroxybutyric Acid..........            2010  I
Methaqualone.......................            2565  I
Mecloqualone.......................            2572  I
JWH-250 (1-Pentyl-3-(2-                        6250  I
 methoxyphenylacetyl) indole).
ADB-PINACA (N-(1-amino-3,3-dimethyl-           7035  I
 1-oxobutan-2-yl)-1-pentyl-1H-
 indazole-3-carboxamide).
JWH-018 (also known as AM678) (1-              7118  I
 Pentyl-3-(1-naphthoyl)indole).
JWH-073 (1-Butyl-3-(1-                         7173  I
 naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-           7200  I
 3-(1-naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2-                        7203  I
 chlorophenylacetyl) indole).
Alpha-ethyltryptamine..............            7249  I
Ibogaine...........................            7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-           7297  I
 [(1R,3S)-3-hydroxycyclohexyl-
 phenol).
CP-47,497 C8 Homologue (5-(1,1-                7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.........            7315  I
2,5-Dimethoxy-4-(n)-                           7348  I
 propylthiophenethylamine (2C-T-7).
Tetrahydrocannabinols..............            7370  I
Mescaline..........................            7381  I
2-(4-Ethylthio-2,5-dimethoxyphenyl)            7385  I
 ethanamine (2C-T-2 ).

[[Page 10465]]

 
3,4,5-Trimethoxyamphetamine........            7390  I
4-Bromo-2,5-dimethoxyamphetamine...            7391  I
4-Bromo-2,5-dimethoxyphenethylamine            7392  I
4-Methyl-2,5-dimethoxyamphetamine..            7395  I
2,5-Dimethoxyamphetamine...........            7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-               7398  I
 naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine...            7399  I
3,4-Methylenedioxyamphetamine......            7400  I
5-Methoxy-3,4-                                 7401  I
 methylenedioxyamphetamine.
N-Hydroxy-3,4-                                 7402  I
 methylenedioxyamphetamine.
3,4-Methylenedioxy-N-                          7404  I
 ethylamphetamine.
3,4-Methylenedioxymethamphetamine..            7405  I
4-Methoxyamphetamine...............            7411  I
5-Methoxy-N-N-dimethyltryptamine...            7431  I
Alpha-methyltryptamine.............            7432  I
Bufotenine.........................            7433  I
Diethyltryptamine..................            7434  I
Dimethyltryptamine.................            7435  I
Psilocybin.........................            7437  I
Psilocyn...........................            7438  I
5-Methoxy-N,N-diisopropyltryptamine            7439  I
N-Ethyl-1-phenylcyclohexylamine....            7455  I
1-(1-Phenylcyclohexyl)pyrrolidine..            7458  I
1-Phenylcyclohexylamine............            7460  II
1-[1-(2-                                       7470  I
 Thienyl)cyclohexyl]piperidine.
Phencyclidine......................            7471  II
1-[1-(2-                                       7473  I
 Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate......            7482  I
N-Methyl-3-piperidyl benzilate.....            7484  I
N-Benzylpiperazine.................            7493  I
4-Methyl-                                      7498  I
 alphapyrrolidinopropiophenone (4-
 MePPP).
2-(2,5-Dimethoxy-4-methylphenyl)               7508  I
 ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl)                7509  I
 ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine             7517  I
 (2C-H).
2-(4-iodo-2,5-dimethoxyphenyl)                 7518  I
 ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl)               7519  I
 ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl)               7521  I
 ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)-                        7524  I
 propylphenyl) ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-                       7532  I
 dimethoxyphenyl) ethanamine (2C-T-
 4 ).
MDPV (3,4-                                     7535  I
 Methylenedioxypyrovalerone).
2-(4-bromo-2,5-dimethoxyphenyl)-N-             7536  I
 (2-methoxybenzyl) ethanamine (25B-
 NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-            7537  I
 (2-methoxybenzyl) ethanamine (25C-
 NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-           7538  I
 methoxybenzyl) ethanamine (25I-
 NBOMe).
Methylone (3,4-Methylenedioxy-N-               7540  I
 methylcathinone).
Butylone...........................            7541  I
Pentylone..........................            7542  I
alpha-pyrrolidinopentiophenone                 7545  I
 ([alpha]-PVP).
alpha-pyrrolidinobutiophenone                  7546  I
 ([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2-               7694  I
 iodobenzoyl) indole).
4-Anilino-N-phenethyl-4-piperidine             8333  II
 (ANPP).
Phenylacetone......................            8501  II
1-Piperidinocyclohexanecarbonitrile            8603  II
Alphaprodine.......................            9010  II
Anileridine........................            9020  II
Cocaine............................            9041  II
Etorphine (except HCl).............            9056  I
Diphenoxylate......................            9170  II
Ecgonine...........................            9180  II
Heroin.............................            9200  I
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Meperidine intermediate-A..........            9232  II
Meperidine intermediate-B..........            9233  II
Meperidine intermediate-C..........            9234  II
Dextropropoxyphene, bulk (non-                 9273  II
 dosage forms).
Morphine...........................            9300  II
Normorphine........................            9313  I
Acetorphine........................            9319  I
U-47700 (3,4-dichloro-N-[2-                    9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                   9551  I
 dimethylamino)cyclohexylmethyl]ben
 zamide)).
Acetylmethadol.....................            9601  I
Allylprodine.......................            9602  I
Alphacetylmethadol except levo-                9603  I
 alphacetylmethadol.
Alphameprodine.....................            9604  I

[[Page 10466]]

 
Alphamethadol......................            9605  I
Benzethidine.......................            9606  I
Betacetylmethadol..................            9607  I
Clonitazene........................            9612  I
Diampromide........................            9615  I
Diethylthiambutene.................            9616  I
Dimethylthiambutene................            9619  I
Ketobemidone.......................            9628  I
Levo-alphacetylmethadol............            9648  II
1-Methyl-4-phenyl-4-                           9661  I
 propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4-                  9663  I
 acetoxypiperidine.
Alfentanil.........................            9737  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Tilidine...........................            9750  I
Tapentadol.........................            9780  II
Fentanyl...........................            9801  II
Para-Fluorofentanyl................            9812  I
3-Methylfentanyl...................            9813  I
Alpha-methylfentanyl...............            9814  I
Acetyl-alpha-methylfentanyl........            9815  I
Acetyl Fentanyl (N-(1-                         9821  I
 phenethylpiperidin-4-yl)-N-
 phenylacetamide).
Beta-hydroxyfentanyl...............            9830  I
Beta-hydroxy-3-methylfentanyl......            9831  I
Alpha-methylthiofentanyl...........            9832  I
3-Methylthiofentanyl...............            9833  I
Furanyl fentanyl (N-(1-                        9834  I
 phenethylpiperidin-4-yl)-N-
 phenylfuran-2-carboxamide).
Thiofentanyl.......................            9835  I
N-(1-phenethylpiperidin-4-yl)-N-               9843  I
 phenyltetrahydrofuran-2-
 carboxamide.
Cyclopropyl Fentanyl...............            9845  I
Fentanyl related-compounds as                  9850  I
 defined in 21 CFR 1308.11&h).
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances as analytical reference standards for distribution to its 
customers. No other activities for these drug codes are authorized for 
this registration.

    Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03616 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P